Evidence map›Paper›PMID 34552326›Full record

ArticleInternational journal of nanomedicine2021

Natural Nano-Drug Delivery System in

Jing Zhao, Qing Zhao, Jing-Ze Lu, Dan Ye, Sheng Mu, Xiao-Di Yang, Wei-Dong Zhang, Bing-Liang Ma

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Chemical Constituents and Their Biological Activities from GenusPharmaceuticals (Basel, Switzerland) · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jing Zhao *Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Qing Zhao *Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Jing-Ze LuDepartment of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Dan YeDepartment of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Sheng MuDepartment of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Xiao-Di YangInnovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Wei-Dong ZhangInstitute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Bing-Liang MaDepartment of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Shanghai University of Traditional Chinese Medicine · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to evaluate the pharmaceutical and pharmacokinetic effects of the natural nanoparticles (Nnps) isolated from

methodsFirstly, Nnps were isolated from

resultsThe Nnps had an average size of 166.6 ± 1.3 nm and Zeta potential of -12.5 ± 0.2 mV. The Nnps were formed by denaturation of co-existing plant proteins with molecular weight < 30 kDa. The Nnps adsorbed or dispersed BBR, thereby promoting BBR transformation from crystal to amorphous form and improving its solubility and dissolution. The Nnps carried and promoted BBR uptake by human colonic adenocarcinoma (Caco-2) cells via caveolae-mediated endocytosis, reducing P-gp-mediated efflux of BBR in mice gut sacs and Madin-Darby canine kidney cells stably expressing the transporter P-gp (MDCK-MDR1) cells. Moreover, the Nnps improved BBR metabolic stability in mouse intestinal S9, promoting BBR intestinal absorption in mice, as shown by increased peak BBR concentration (C

conclusionThe proteinaceous nanoparticles isolated from

Indexed as

BerberineDrugs, Chinese HerbalAnimalsCaco-2 CellsCoptis chinensisDogsHumansIntestinal AbsorptionMiceBerberineCoptidis rhizoma extractDrugs, Chinese Herbalberberine hydrochloridedrug delivery systemherbal extractnatural nanoparticlespharmacokinetic synergy

Identifiers

PMID34552326
PMCPMC8451076
OpenAlexW3200696843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.